Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article
space
 arrow  PDF of this article
(PDFs free after 6 months)
space
 arrow  Summary for Patients
space
 arrow  Summary for Patients (PDF)
space
 arrow  Figures/Tables List
space
 arrow  Related articles in Annals
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Calvert, P. M.
space
  arrow  Frucht, H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

REVIEW

The Genetics of Colorectal Cancer

right arrow Paula M. Calvert, MD, and Harold Frucht, MD

1 October 2002 | Volume 137 Issue 7 | Pages 603-612

Colon cancer is a common disease that can be sporadic, familial, or inherited. Recent advances have contributed to the understanding of the molecular basis of these various patterns of colon cancer. Germline genetic mutations are the basis of inherited colon cancer syndromes; an accumulation of somatic mutations in a cell is the basis of sporadic colon cancer; and, in Ashkenazi Jewish persons, a mutation that was previously thought to be a polymorphism may cause familial colon cancer. Mutations of three different classes of genes have been described in colon cancer etiology: oncogenes, suppressor genes, and mismatch repair genes. Knowledge of many of the specific mutations responsible for colon carcinogenesis allows an understanding of the phenotypic manifestations observed and forms the basis of genetic testing for inherited disease. Although genetic testing is possible and available, it is only an adjunct to the clinical management of persons at risk for colon cancer and patients with colon cancer. As a result of advances in the understanding of the molecular causes of colon cancer and the availability of colon cancer screening methods such as colonoscopy, it should be possible to prevent the vast majority of colon cancer in our society. Practicing clinicians should recognize the patterns of clinical colon cancer, understand its causes, and be able to use genetic testing and endoscopic screening for prevention.

Author and Article Information
space

From Fox Chase Cancer Center, Philadelphia, Pennsylvania; and College of Physicians and Surgeons, Columbia University, New York, New York.

Acknowledgments: The authors thank Kathy Buchheit and Ellen Ragan for editorial and administrative support. They also thank Alfred G. Knudson, MD, PhD, for ongoing teaching, insight, and support; for careful review of the manuscript; and for helpful suggestions.

Grant Support: By the National Cancer Institute (CA 70335) (Dr. Frucht).

Requests for Single Reprints: Harold Frucht, MD, Division of Digestive and Liver Diseases, College of Physicians and Surgeons, Columbia University, 630 West 168th Street, Box 83, New York, NY 10032.

Current Author Addresses: Dr. Calvert: Tullamore General Hospital, Arden Road, Tullamore, County Offaly, Ireland.

Dr. Frucht: College of Physicians and Surgeons, Columbia University, Division of Digestive and Liver Diseases, 630 West 168th Street, Box 83, New York, NY 10032.


Related articles in Annals:

Summaries for Patients
The Genetics of Colorectal Cancer
Annals 2002 137: I-48. [Full Text]  



This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
D. Z. J. Chu, G. Gibson, D. David, and Y. Yen
The Surgeon's Role in Cancer Prevention. The Model in Colorectal Carcinoma
Ann. Surg. Oncol., November 1, 2007; 14(11): 3054 - 3069.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
M. R. De Miglio, P. Virdis, D. F. Calvisi, D. Mele, M. R. Muroni, M. Frau, F. Pinna, M. L. Tomasi, M. M. Simile, R. M. Pascale, et al.
Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/{beta}-catenin pathway and progression of early lesions in the rat
Carcinogenesis, November 1, 2007; 28(11): 2367 - 2374.
[Abstract] [Full Text] [PDF]


Home page
Jpn J Clin OncolHome page
Z.-Z. Zhu, A.-Z. Wang, H.-R. Jia, X.-X. Jin, X.-L. He, L.-F. Hou, and G. Zhu
Association of the TP53 Codon 72 Polymorphism with Colorectal Cancer in a Chinese Population
Jpn. J. Clin. Oncol., May 1, 2007; 37(5): 385 - 390.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
S. G Baker and J. Kaprio
Common susceptibility genes for cancer: search for the end of the rainbow.
BMJ, May 13, 2006; 332(7550): 1150 - 1152.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
R. J. Canter, S. B. Kesmodel, D. F. Heitjan, N. K. Veeramachaneni, N. A. Mokadam, J. A. Drebin, and D. L. Fraker
Suppression of {beta}-Catenin by Antisense Oligomers Augments Tumor Response to Isolated Limb Perfusion in a Rodent Model of Adenomatous Polyposis Coli-Mutant Colon Cancer
Ann. Surg. Oncol., September 1, 2005; 12(9): 733 - 742.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
U. H. Frey, H. Alakus, J. Wohlschlaeger, K. J. Schmitz, G. Winde, H. G. van Calker, K.-H. Jockel, W. Siffert, and K. W. Schmid
GNAS1 T393C Polymorphism and Survival in Patients with Sporadic Colorectal Cancer
Clin. Cancer Res., July 15, 2005; 11(14): 5071 - 5077.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. C.A. van Kouwen, F. M. Nagengast, J. B.M.J. Jansen, W. J.G. Oyen, and J. P.H. Drenth
2-(18F)-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Detects Clinical Relevant Adenomas of the Colon: A Prospective Study
J. Clin. Oncol., June 1, 2005; 23(16): 3713 - 3717.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Liu, W. Su, E. A. Thompson, M. Leitges, N. R. Murray, and A. P. Fields
Protein Kinase C{beta}II Regulates Its Own Expression in Rat Intestinal Epithelial Cells and the Colonic Epithelium in Vivo
J. Biol. Chem., October 29, 2004; 279(44): 45556 - 45563.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. E. Moran, D. H. Hunt, S. H. Javid, M. Redston, A. M. Carothers, and M. M. Bertagnolli
Apc Deficiency Is Associated with Increased Egfr Activity in the Intestinal Enterocytes and Adenomas of C57BL/6J-Min/+ Mice
J. Biol. Chem., October 8, 2004; 279(41): 43261 - 43272.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
B Perez-Ordonez, N N Huynh, K W Berean, and R C K Jordan
Expression of mismatch repair proteins, {beta} catenin, and E cadherin in intestinal-type sinonasal adenocarcinoma
J. Clin. Pathol., October 1, 2004; 57(10): 1080 - 1083.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
D. Feskanich, J. Ma, C. S. Fuchs, G. J. Kirkner, S. E. Hankinson, B. W. Hollis, and E. L. Giovannucci
Plasma Vitamin D Metabolites and Risk of Colorectal Cancer in Women
Cancer Epidemiol. Biomarkers Prev., September 1, 2004; 13(9): 1502 - 1508.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Zhang, P. Z. Anastasiadis, Y. Liu, E. A. Thompson, and A. P. Fields
Protein Kinase C (PKC) {beta}II Induces Cell Invasion through a Ras/Mek-, PKC{iota}/Rac 1-dependent Signaling Pathway
J. Biol. Chem., May 21, 2004; 279(21): 22118 - 22123.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
S. L. Kirstein and P. A. Insel
Autonomic Nervous System Pharmacogenomics: A Progress Report
Pharmacol. Rev., March 1, 2004; 56(1): 31 - 52.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
H. Kattlove and R. J. Winn
Ongoing Care of Patients After Primary Treatment for Their Cancer
CA Cancer J Clin, May 1, 2003; 53(3): 172 - 196.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 2002 by the American College of Physicians.